Viewing Study NCT04885920


Ignite Creation Date: 2025-12-25 @ 4:27 AM
Ignite Modification Date: 2025-12-26 @ 3:31 AM
Study NCT ID: NCT04885920
Status: COMPLETED
Last Update Posted: 2024-04-16
First Post: 2021-05-12
Is NOT Gene Therapy: False
Has Adverse Events: False

Brief Title: A Study on Administration Choices of Vedolizumab and Outcomes for Adults With Inflammatory Bowel Disease (IBD) (VARIETY - CROATIA AND SLOVENIA)
Sponsor: Takeda
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module